<DOC>
	<DOCNO>NCT00266409</DOCNO>
	<brief_summary>An 8-week , open-label trial 848 subject 212 site compare time response symptom anxiety subject treat Niravam™ newly prescribe Selective Serotonin Reuptake Inhibitor ( SSRI ) Serotonin Norepinephrine Reuptake Inhibitor ( SNRI ) subject treated newly prescribe SSRI/SNRI alone . Subjects must least 18 year age positive Generalized Anxiety Disorder ( GAD ) Panic Disorder . Subjects randomize receive concomitant Niravam™ SSRI/SNRI SSRI/SNRI alone study . Most symptom evaluation do use automate phone interview system . There 4 clinic visit .</brief_summary>
	<brief_title>Trial Compare Time Response Symptoms Anxiety Concomitant Treatment With Niravam™ SSRI SNRI Treatment With SSRI SNRI Alone Subjects With Generalized Anxiety Disorder Panic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Serotonin Noradrenaline Reuptake Inhibitors</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Must least 18 year age . Diagnosed Investigator primary Generalized Anxiety Disorder ( GAD ) and/or primary Panic Disorder without agoraphobia , either primary episode recurrence , positive GAD Panic Disorder MHS ( Mental Health Screener ) ) . Receiving new prescription SSRI SNRI indicate GAD Panic Disorder without agoraphobia . Definition new prescription case recurrence symptom prescription refill prescription SSRI SNRI past 6 month . Subject inform give ample time opportunity think his/her participation give his/her write informed consent . Presence medical condition presence schizophrenia , bipolar disorder , alcohol abuse/dependence primary major psychiatric disorder , opinion Investigator , would jeopardize subject compromise subject 's ability participate trial . Is current suicide risk opinion Investigator . Has initiate cognitive therapy within two month Study Day 1 . Does speak English hear well enough able perform Hamilton Anxiety ( HAMA ) Rating Scale Mental Health Screener ( MHS ) Interactive Voice Response System ( IVRS ) . Has take benzodiazepine within past 30 day . History hypersensitivity allergic response component SSRIs , SNRIs , benzodiazepine , relate drug . If female childbearing potential , pregnant , nursing , use appropriate birth control method . Presence contraindication SSRI SNRI prescribe per specific package insert . Presence acute narrow angle glaucoma take ketoconazole itraconazole , contraindication Niravam per package insert . History phenylketonuria ( PKU ) . Participation previous clinical trial within 30 day prior Study Day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>